202 related articles for article (PubMed ID: 29353288)
1. Quercetin Inhibits Breast Cancer Stem Cells via Downregulation of Aldehyde Dehydrogenase 1A1 (ALDH1A1), Chemokine Receptor Type 4 (CXCR4), Mucin 1 (MUC1), and Epithelial Cell Adhesion Molecule (EpCAM).
Wang R; Yang L; Li S; Ye D; Yang L; Liu Q; Zhao Z; Cai Q; Tan J; Li X
Med Sci Monit; 2018 Jan; 24():412-420. PubMed ID: 29353288
[TBL] [Abstract][Full Text] [Related]
2. Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells.
Ciccone V; Terzuoli E; Donnini S; Giachetti A; Morbidelli L; Ziche M
J Exp Clin Cancer Res; 2018 Dec; 37(1):311. PubMed ID: 30541574
[TBL] [Abstract][Full Text] [Related]
3. MUC1-C oncoprotein activates ERK→C/EBPβ signaling and induction of aldehyde dehydrogenase 1A1 in breast cancer cells.
Alam M; Ahmad R; Rajabi H; Kharbanda A; Kufe D
J Biol Chem; 2013 Oct; 288(43):30892-903. PubMed ID: 24043631
[TBL] [Abstract][Full Text] [Related]
4. Quercetin‑3‑methyl ether suppresses human breast cancer stem cell formation by inhibiting the Notch1 and PI3K/Akt signaling pathways.
Cao L; Yang Y; Ye Z; Lin B; Zeng J; Li C; Liang T; Zhou K; Li J
Int J Mol Med; 2018 Sep; 42(3):1625-1636. PubMed ID: 29956731
[TBL] [Abstract][Full Text] [Related]
5. NOTCH-induced aldehyde dehydrogenase 1A1 deacetylation promotes breast cancer stem cells.
Zhao D; Mo Y; Li MT; Zou SW; Cheng ZL; Sun YP; Xiong Y; Guan KL; Lei QY
J Clin Invest; 2014 Dec; 124(12):5453-65. PubMed ID: 25384215
[TBL] [Abstract][Full Text] [Related]
6. Midkine downregulation increases the efficacy of quercetin on prostate cancer stem cell survival and migration through PI3K/AKT and MAPK/ERK pathway.
Erdogan S; Turkekul K; Dibirdik I; Doganlar O; Doganlar ZB; Bilir A; Oktem G
Biomed Pharmacother; 2018 Nov; 107():793-805. PubMed ID: 30142541
[TBL] [Abstract][Full Text] [Related]
7. Effect of fibroblasts on breast cancer cell mammosphere formation and regulation of stem cell-related gene expression.
Zhang F; Song C; Ma Y; Tang L; Xu Y; Wang H
Int J Mol Med; 2011 Sep; 28(3):365-71. PubMed ID: 21573501
[TBL] [Abstract][Full Text] [Related]
8. Resistance of primary breast cancer cells with enhanced pluripotency and stem cell activity to sex hormonal stimulation and suppression.
Nasr M; Farghaly M; Elsaba T; El-Mokhtar M; Radwan R; Elsabahy M; Abdelkareem A; Fakhry H; Mousa N
Int J Biochem Cell Biol; 2018 Dec; 105():84-93. PubMed ID: 30359767
[TBL] [Abstract][Full Text] [Related]
9. Effects of ellipticine on ALDH1A1-expressing breast cancer stem cells--an in vitro and in silico study.
Pandrangi SL; Chikati R; Chauhan PS; Kumar CS; Banarji A; Saxena S
Tumour Biol; 2014 Jan; 35(1):723-37. PubMed ID: 23982874
[TBL] [Abstract][Full Text] [Related]
10. A novel biphenyl urea derivate inhibits the invasion of breast cancer through the modulation of CXCR4.
Zhan Y; Zhang H; Li J; Zhang Y; Zhang J; He L
J Cell Mol Med; 2015 Jul; 19(7):1614-23. PubMed ID: 25753200
[TBL] [Abstract][Full Text] [Related]
11. Targeting breast stem cells with the cancer preventive compounds curcumin and piperine.
Kakarala M; Brenner DE; Korkaya H; Cheng C; Tazi K; Ginestier C; Liu S; Dontu G; Wicha MS
Breast Cancer Res Treat; 2010 Aug; 122(3):777-85. PubMed ID: 19898931
[TBL] [Abstract][Full Text] [Related]
12. Activation of ALDH1A1 in MDA-MB-468 breast cancer cells that over-express CYP2J2 protects against paclitaxel-dependent cell death mediated by reactive oxygen species.
Allison SE; Chen Y; Petrovic N; Zhang J; Bourget K; Mackenzie PI; Murray M
Biochem Pharmacol; 2017 Nov; 143():79-89. PubMed ID: 28756208
[TBL] [Abstract][Full Text] [Related]
13. A differential role for CXCR4 in the regulation of normal versus malignant breast stem cell activity.
Ablett MP; O'Brien CS; Sims AH; Farnie G; Clarke RB
Oncotarget; 2014 Feb; 5(3):599-612. PubMed ID: 24583601
[TBL] [Abstract][Full Text] [Related]
14. Bifunctional fused polypeptide inhibits the growth and metastasis of breast cancer.
Liang AL; Qian HL; Zhang TT; Zhou N; Wang HJ; Men XT; Qi W; Zhang PP; Fu M; Liang X; Lin C; Liu YJ
Drug Des Devel Ther; 2015; 9():5671-86. PubMed ID: 26527862
[TBL] [Abstract][Full Text] [Related]
15. Aldehyde dehydrogenase 1A1 up-regulates stem cell markers in benzo[a]pyrene-induced malignant transformation of BEAS-2B cells.
Liu Y; Lu R; Gu J; Chen Y; Zhang X; Zhang L; Wu H; Hua W; Zeng J
Environ Toxicol Pharmacol; 2016 Jul; 45():241-50. PubMed ID: 27331345
[TBL] [Abstract][Full Text] [Related]
16. Eupolyphaga sinensis Walker Ethanol Extract Suppresses Cell Growth and Invasion in Human Breast Cancer Cells.
Zhan Y; Zhang H; Liu R; Wang W; Qi J; Zhang Y
Integr Cancer Ther; 2016 Mar; 15(1):102-12. PubMed ID: 26242891
[TBL] [Abstract][Full Text] [Related]
17. Esculentoside A suppresses breast cancer stem cell growth through stemness attenuation and apoptosis induction by blocking IL-6/STAT3 signaling pathway.
Liu C; Dong L; Sun Z; Wang L; Wang Q; Li H; Zhang J; Wang X
Phytother Res; 2018 Nov; 32(11):2299-2311. PubMed ID: 30080291
[TBL] [Abstract][Full Text] [Related]
18. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
19. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
Kang H; Mansel RE; Jiang WG
Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
[TBL] [Abstract][Full Text] [Related]
20. Up-modulation of PLC-β2 reduces the number and malignancy of triple-negative breast tumor cells with a CD133
Brugnoli F; Grassilli S; Lanuti P; Marchisio M; Al-Qassab Y; Vezzali F; Capitani S; Bertagnolo V
BMC Cancer; 2017 Sep; 17(1):617. PubMed ID: 28870198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]